Curie Medika Indonesia is primarily engaged in medical equipment and supplies activity. Its headquarters is located in Dki Jakarta. The company was founded in 2018. Curie Medika Indonesia was founded by a group of healthcare professionals and entrepreneurs with a vision to enhance the quality of healthcare services in Indonesia through the provision of high-quality medical equipment and supplies. The company focuses on both the distribution and manufacturing of medical devices, with a primary emphasis on innovative and cost-effective solutions for hospitals, clinics, and healthcare providers. Curie Medika Indonesia operates several branches across major cities in Indonesia, including Surabaya, Bandung, and Medan, ensuring a robust local geographical footprint. The company offers a wide range of products, including diagnostic equipment, surgical instruments, and patient care supplies. Some of their well-known product brands include MedikaCare and CurieTech. In addition to its domestic operations, Curie Medika Indonesia has begun exploring export markets in Southeast Asia, aiming to expand its presence in countries such as Malaysia, Thailand, and the Philippines. The company is actively seeking partnerships with international medical technology firms to enhance its product offerings and technological capabilities. Curie Medika Indonesia is a member of the Indonesian Medical Device Producers Association (ASPAKI) and participates in various healthcare exhibitions and forums to stay at the forefront of industry trends. The company is committed to improving healthcare accessibility and quality through innovation and collaboration, with a mission to become a leading provider of medical solutions in the region.
Headquarters
RT 001 RW 04
Central Jakarta; Jakarta;
Postal Code: 10160
Contact Details: Purchase the Pt Curie Medika Indonesia report to view the information.
Website: http://www.curiemedika.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service